Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.
about
Gentian violet: a 19th century drug re-emerges in the 21st centuryUpdates of reactive oxygen species in melanoma etiology and progression.PHIPing out: a genetic basis for tumor ulceration.VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism and serves as a marker of poor prognosis for cancer patientsRedox-modulating agents target NOX2-dependent IKKε oncogenic kinase expression and proliferation in human breast cancer cell linesTreatment of in-transit melanoma with intralesional bacillus Calmette-Guérin (BCG) and topical imiquimod 5% cream: a report of 3 cases.Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.Gentian violet induces wtp53 transactivation in cancer cellsThe antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cellsToll-like receptors and cutaneous melanoma.Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency.Redox Regulation of Inflammatory Processes Is Enzymatically Controlled.Targeting the duality of cancer.Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial.Immunotolerant indoleamine-2,3-dioxygenase is increased in condyloma acuminata.
P2860
Q34377198-F6AB15E3-E066-4681-A26F-B79B24E42273Q34403921-F924C0A7-4B76-4727-9D01-BAD1024B9095Q35546486-BCDC44F0-B036-45CB-8E37-11E2E10D7898Q35698934-B6663EDB-FAF5-4400-B0D9-D7621696AD95Q35880182-7B6EEA99-B9D1-4777-AA07-BA373824412FQ36322376-701BDC6A-5C2C-4994-8B3C-4DF12245A396Q36580091-BA6F2812-4AB5-4BC2-8D9D-FE8DE0AA86D4Q37688664-0893073F-920B-47FA-906E-C7438F23EE6BQ38261369-84452E7C-C598-4287-8DD3-1F548D21B366Q38944587-62214FA7-435C-4CFA-A1C8-C87D2E85EF85Q39023996-ACD4D079-7254-4684-AD61-EF327C69FE6DQ42977967-5803FB95-F39A-4B83-AF88-DA8624439ADAQ45338276-939924BE-3E9F-4815-85B7-A3D5F875D6EEQ52539731-3523A01F-5A9E-431C-98A1-6A15E2BC3F21Q52597538-48A51E7E-C0AD-4A92-9BB1-611EC4894022Q52797663-792E2E68-B316-403E-BBD0-469D44FB81BC
P2860
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.
@ast
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.
@en
type
label
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.
@ast
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.
@en
prefLabel
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.
@ast
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.
@en
P2093
P2860
P1476
Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.
@en
P2093
Anne Seidler
Charles Kovach
Jack L Arbiser
Maria Bips
Michael Y Bonner
P2860
P356
10.1016/J.JAAD.2011.10.028
P407
P577
2012-08-01T00:00:00Z